tetano
Editor, Senior Moderator
J Chem Inf Model
. 2021 Jun 22.
doi: 10.1021/acs.jcim.1c00241. Online ahead of print.
Anchor-Locker Binding Mechanism of the Coronavirus Spike Protein to Human ACE2: Insights from Computational Analysis
Yalong Cong[SUP] 1 [/SUP], Yinghui Feng[SUP] 1 [/SUP], Hui Ni[SUP] 2 [/SUP], Fengdong Zhi[SUP] 1 [/SUP], Yulu Miao[SUP] 1 [/SUP], Bohuan Fang[SUP] 1 [/SUP], Lujia Zhang[SUP] 1 3 [/SUP], John Z H Zhang[SUP] 1 3 4 [/SUP]
Affiliations
Abstract
COVID-19 has emerged as the most serious international pandemic in early 2020 and the lack of comprehensive knowledge in the recognition and transmission mechanisms of this virus hinders the development of suitable therapeutic strategies. The specific recognition during the binding of the spike glycoprotein (S protein) of coronavirus to the angiotensin-converting enzyme 2 (ACE2) in the host cell is widely considered the first step of infection. However, detailed insights on the underlying mechanism of dynamic recognition and binding of these two proteins remain unknown. In this work, molecular dynamics simulation and binding free energy calculation were carried out to systematically compare and analyze the receptor-binding domain (RBD) of six coronavirus' S proteins. We found that affinity and stability of the RBD from SARS-CoV-2 under the binding state with ACE2 are stronger than those of other coronaviruses. The solvent-accessible surface area (SASA) and binding free energy of different RBD subunits indicate an "anchor-locker" recognition mechanism involved in the binding of the S protein to ACE2. Loop 2 (Y473-F490) acts as an anchor for ACE2 recognition, and Loop 3 (G496-V503) locks ACE2 at the other nonanchoring end. Then, the charged or long-chain residues in the β-sheet 1 (N450-F456) region reinforce this binding. The proposed binding mechanism was supported by umbrella sampling simulation of the dissociation process. The current computational study provides important theoretical insights for the development of new vaccines against SARS-CoV-2.
. 2021 Jun 22.
doi: 10.1021/acs.jcim.1c00241. Online ahead of print.
Anchor-Locker Binding Mechanism of the Coronavirus Spike Protein to Human ACE2: Insights from Computational Analysis
Yalong Cong[SUP] 1 [/SUP], Yinghui Feng[SUP] 1 [/SUP], Hui Ni[SUP] 2 [/SUP], Fengdong Zhi[SUP] 1 [/SUP], Yulu Miao[SUP] 1 [/SUP], Bohuan Fang[SUP] 1 [/SUP], Lujia Zhang[SUP] 1 3 [/SUP], John Z H Zhang[SUP] 1 3 4 [/SUP]
Affiliations
- PMID: 34156227
- DOI: 10.1021/acs.jcim.1c00241
Abstract
COVID-19 has emerged as the most serious international pandemic in early 2020 and the lack of comprehensive knowledge in the recognition and transmission mechanisms of this virus hinders the development of suitable therapeutic strategies. The specific recognition during the binding of the spike glycoprotein (S protein) of coronavirus to the angiotensin-converting enzyme 2 (ACE2) in the host cell is widely considered the first step of infection. However, detailed insights on the underlying mechanism of dynamic recognition and binding of these two proteins remain unknown. In this work, molecular dynamics simulation and binding free energy calculation were carried out to systematically compare and analyze the receptor-binding domain (RBD) of six coronavirus' S proteins. We found that affinity and stability of the RBD from SARS-CoV-2 under the binding state with ACE2 are stronger than those of other coronaviruses. The solvent-accessible surface area (SASA) and binding free energy of different RBD subunits indicate an "anchor-locker" recognition mechanism involved in the binding of the S protein to ACE2. Loop 2 (Y473-F490) acts as an anchor for ACE2 recognition, and Loop 3 (G496-V503) locks ACE2 at the other nonanchoring end. Then, the charged or long-chain residues in the β-sheet 1 (N450-F456) region reinforce this binding. The proposed binding mechanism was supported by umbrella sampling simulation of the dissociation process. The current computational study provides important theoretical insights for the development of new vaccines against SARS-CoV-2.